A systems pharmacology approach based on oncogenic signalling pathways to determine the mechanisms of action of natural products in breast cancer from transcriptome data
Abstract Background Narrow spectrum of action through limited molecular targets and unforeseen drug-related toxicities have been the main reasons for drug failures at the phase I clinical trials in complex diseases. Most plant-derived compounds with medicinal values possess poly-pharmacologic proper...
Saved in:
Main Authors: | Regan Odongo (Author), Asuman Demiroglu-Zergeroglu (Author), Tunahan Çakır (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
by: Michelle M. Williams, et al.
Published: (2021) -
Natural products for the treatment of allergic rhinitis: focus on cellular signaling pathways and pharmacological targets
by: Shabnam Moradi, et al.
Published: (2024) -
Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies From Concept to Practice [Internet]
Published: (2023) -
Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies From Concept to Practice [Internet]
Published: (2023) -
Pharmacological effects of higenamine based on signalling pathways and mechanism of action
by: De-ta Chen, et al.
Published: (2022)